Listed by the USPTO as FLANAGAN, BEVERLY MEINDL
Tech Center 3900 • Art Units: 3746 3773 3794 3993
This examiner grants 73% of resolved cases
FLANAGAN, BEVERLY MEINDL is assigned to Tech Center 3900 and Art Unit 3746. She has 231 resolved cases, a 73.2% allowance rate, and a median of 847 days to allowance. The record shows a favorable allowance outcome, with resolution generally taking more than two years, while the case volume is narrower than a high-volume examiner record.
Interviews correspond to a 20.5% lift in allowance outcomes. That association supports treating interviews as a practical tool for moving suitable cases toward allowance. The listed companies are Boston Scientific, Intuitive Surgical Operations, and Abbott Laboratories. The listed firms include Nelson Mullins Riley & Scarborough, Dentons Durham Jones Pinegar, and Knobbe Martens.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18991089 | ELECTROPORATION ABLATION FROM TISSUE-CONTACTING ELECTRODES | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18810160 | WIDE-AREA FOCAL ABLATION CATHETER HAVING INSULATED PORTIONS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18608757 | DILATOR WITH BUILT-IN BALLOON FOR USE DURING TRANSSEPTAL PROCEDURE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18496706 | MEDICAL DEVICE WITH RETRACTABLE SENSOR | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 18858738 | PERMEABILIZATION AND ELECTROLYSIS FOR ABLATION WITH EXTRACELLULAR MATRIX RETENTION | Non-Final OA | Intuitive Surgical Operations, Inc. |
| 18818408 | HELICAL ELECTRODE TREATMENT DEVICE AND RELATED METHODS OF TREATMENT | Non-Final OA | Intuitive Surgical Operations, Inc. |
| 19013666 | SYSTEMS AND METHODS FOR PULSED FIELD ABLATION | Non-Final OA | St. Jude Medical, Cardiology Division, Inc. |
| 18133750 | SYSTEMS AND METHODS FOR ELECTROPORATION USING ARBITRARY ELECTRODE ADDRESSING | Final Rejection | St. Jude Medical, Cardiology Division, Inc. |
| 19193320 | CRYOABLATION CATHETER FOR DUODENAL PAPILLA INSERTION AND A CRYOABLATION CATHETER SYSTEM | Non-Final OA | KANEKA CORPORATION |
| 18721634 | BALLOON CATHETER AND BALLOON CATHETER SYSTEM | Non-Final OA | Toray Industries, Inc. |
| 18601244 | ASSISTED SURGICAL DEVICE OPERATION FROM CAMERA FEED | Non-Final OA | Arthrex, Inc. |
| 18499063 | MINIMALLY INVASIVE INTERVENTIONAL DEVICE AND MINIMALLY INVASIVE INTERVENTIONAL APPARATUS INCLUDING MINIMALLY INVASIVE INTERVENTIONAL DEVICE | Non-Final OA | PEKING UNIVERSITY |
| 19123645 | CATHETER SHAFT CONSTRUCTION WITH EXPOSED BRAID AS ELECTRODE(S) | Non-Final OA | Medtronic, Inc. |
| 18879530 | INTERVENTIONAL GUIDANCE | Non-Final OA | MEDTRONIC, INC. |
| 18947594 | ASSISTANCE DEVICE, ASSISTANCE METHOD, AND RECORDING MEDIUM | Non-Final OA | OLYMPUS MEDICAL SYSTEMS CORP. |
| 18832782 | Reusable Thermal Contact Pad | Final Rejection | C. R. Bard, Inc. |
| 18028305 | GALLBLADDER CRYOABLATION DEVICE AND METHOD | Final Rejection | Arizona Board of Regents on Behalf of the University of Arizona |
| 18782908 | CONTROL METHOD FOR TREATMENT DEVICE, TREATMENT TIP AND TREATMENT DEVICE | Final Rejection | SHENZHEN PENINSULA MEDICAL GROUP |
| 18642684 | SURGICAL PROBE DEVICE, AND SYSTEMS AND METHODS FOR COOLING THE SAME | Final Rejection | Monteris Medical Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy73.2% of resolved applications examined by Beverly Meindl Flanagan were allowed (231 resolved cases), compared with 68.0% across Art Unit 3746 over the last five years.
This examiner's interview lift is +20.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Beverly Meindl Flanagan took 847 days on average from filing to allowance.
Beverly Meindl Flanagan examines applications in Art Unit 3746 in Tech Center 3900.
